# A Clinical Study to Evaluate the Safety,Tolerability and PK of ZYT1, Following Oral Administration in Healthy Volunteers

> **NCT01543269** · PHASE1 · TERMINATED · sponsor: **Zydus Lifesciences Limited** · enrollment: 24 (actual)

## Conditions studied

- Obesity
- Lipid Disorders

## Interventions

- **DRUG:** ZYT1
- **DRUG:** Placebo tablets

## Key facts

- **NCT ID:** NCT01543269
- **Lead sponsor:** Zydus Lifesciences Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-02
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 24 (ACTUAL)
- **Why stopped:** Safety concerns
- **Last updated:** 2015-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01543269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01543269, "A Clinical Study to Evaluate the Safety,Tolerability and PK of ZYT1, Following Oral Administration in Healthy Volunteers". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01543269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*